Heim600812 • SHA
add
North China Pharmaceutical Group Corp
Við síðustu lokun
5,56 ¥
Dagbil
5,53 ¥ - 5,60 ¥
Árabil
3,83 ¥ - 6,66 ¥
Meðalmagn
18,86 m.
V/H-hlutf.
119,92
A/V-hlutfall
0,18%
Aðalkauphöll
SHA
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(CNY) | sep. 2024info | Breyting á/á |
---|---|---|
Tekjur | 2,33 ma. | -15,04% |
Rekstrarkostnaður | 539,22 m. | -19,20% |
Nettótekjur | 30,48 m. | 2.035,14% |
Hagnaðarhlutfall | 1,31 | 2.520,00% |
Hagnaður á hvern hlut | — | — |
EBITDA | 362,65 m. | 6,65% |
Virkt skatthlutfall | 32,92% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(CNY) | sep. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 1,72 ma. | 15,99% |
Heildareignir | 21,71 ma. | 0,92% |
Heildarskuldir | 15,10 ma. | -0,95% |
Eigið fé alls | 6,61 ma. | — |
Útistandandi hlutabréf | 1,72 ma. | — |
Eiginfjárgengi | 1,78 | — |
Arðsemi eigna | 2,06% | — |
Ávöxtun eigin fjár | 2,47% | — |
Peningaflæði
Breyting á handbæru fé
(CNY) | sep. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | 30,48 m. | 2.035,14% |
Handbært fé frá rekstri | 175,21 m. | -46,70% |
Reiðufé frá fjárfestingum | -153,19 m. | 10,80% |
Reiðufé frá fjármögnun | -76,80 m. | 67,74% |
Breyting á handbæru fé | -55,38 m. | 30,27% |
Frjálst peningaflæði | -660,87 m. | -459,21% |
Um
North China Pharmaceutical Group Corp., is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million. Wikipedia
Stofnsett
20. des. 1992
Starfsfólk
10.159